China Counterfeit Drugs

News & Analysis as of

LIfe Sciences Spotlight (Asia Pacific) Unravelling the Helix

In this edition of Life Sciences Spotlight, members in the DLA Piper Life Sciences team will assist in unravelling the legal aspects of a real-world Life Sciences dilemma. In this issue, DLA Piper’s IP specialist, Ian Jebbitt...more

China Life Sciences and Health Industry Client Briefing – July 2012 (August 8, 2012)

In This Issue: - Counterfeit Drug Crackdown in China (Xinhua News Agency 2012-08-05) – August 5, 2012 - China Agencies Drafting Policies to Accelerate Development of Medical Devices, Supporting Fund to be...more

2 Results
View per page
Page: of 1
JD Supra Readers' Choice 2016 Awards

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.